Skip to main content
Vivo Bio tech Ltd. logo

Vivo Bio tech Ltd. — Investor Relations & Filings

Ticker · 511509 ISIN · INE380K01017 LEI · 98450079E4M2CR80D882 BSE.NS Professional, scientific and technical activities
Open in API
Filings indexed 440 across all filing types
Latest filing 2024-10-15 Regulatory Filings
Country IN India
Listing BSE.NS 511509

About Vivo Bio tech Ltd.

http://www.vivobio.com/

Vivo Bio Tech Ltd. is a preclinical Contract Research Organization (CRO) providing comprehensive drug discovery and development services. The company specializes in conducting in vivo preclinical studies, including toxicology, pharmacology, and pharmacokinetic evaluations. It operates advanced facilities for the breeding and distribution of Specific Pathogen Free (SPF) laboratory animal models, maintained through strategic partnerships with global leaders like Taconic Biosciences. Vivo Bio Tech offers regulatory-compliant services such as safety assessment, efficacy testing, and specialized research models to support pharmaceutical and biotechnology sectors. Its operations are characterized by adherence to Good Laboratory Practice (GLP) standards and AAALAC accreditation, ensuring high-quality data for global regulatory submissions.

Recent filings

Filing Released Lang Actions
Please find enclosed certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
Regulatory Filings
2024-10-15 English
Please find enclosed Voting Results for the 37th Annual General Meeting
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a formal communication addressed to a stock exchange (BSE Limited) reporting the voting results of the 37th Annual General Meeting (AGM) held on September 30, 2024. It references compliance with SEBI regulations (Listing Obligations and Disclosure Requirements) and includes detailed voting outcomes for multiple resolutions passed at the AGM. The document does not contain the full AGM materials or presentations but specifically reports the official voting results and the Scrutinizer's report summary. This matches the definition of 'Declaration of Voting Results & Voting Rights Announcements' (DVA). The document length (8901 characters) and content focus on voting results rather than the full AGM report or presentations, so it is not AGM Information (AGM-R). Therefore, the correct classification is DVA with high confidence.
2024-10-01 English
Please find enclosed Scrutinizers Report for 37th Annual General Meeting
Regulatory Filings
2024-10-01 English
Please find enclosed proceedings of the 37th Annual General Meeting
AGM Information Classification · 95% confidence The document is a detailed summary of the proceedings of the 37th Annual General Meeting (AGM) of Vivo Bio Tech Limited held on September 30, 2024. It includes information about the meeting's conduct, attendance, agenda items, voting procedures, and compliance with regulatory circulars. The document does not contain full financial statements or detailed financial performance data, but rather focuses on the meeting proceedings and related disclosures. This matches the definition of 'AGM Information' which covers presentations and materials shared during the AGM. The document length (8574 characters) and content confirm it is not a brief announcement or a report publication notice but a substantive summary of the AGM proceedings.
2024-09-30 English
Closure of Trading Window
Regulatory Filings Classification · 95% confidence The document is a short notice informing the stock exchange about the closure of the trading window for insiders due to upcoming financial results announcement. It references SEBI regulations and the company's internal code but does not contain any financial data or detailed report. The document length is only 1482 characters, indicating it is a brief announcement rather than a full report. It does not present financial results or detailed analysis but merely informs about the trading window closure period related to the upcoming un-audited financial results. Therefore, it is best classified as a Regulatory Filing (RNS), which covers general regulatory announcements and compliance notices that do not fit other categories.
2024-09-28 English
Newspaper publication of 37th AGM, e-voting and book closure
AGM Information Classification · 95% confidence The document is a letter addressed to BSE Limited regarding the newspaper publication of the Notice of the 37th Annual General Meeting (AGM) of the company. It references compliance with SEBI regulations about disclosure of the AGM notice, book closure, and e-voting. The content is about the announcement and publication of the AGM notice in newspapers, not the AGM materials themselves or the meeting proceedings. The document length is about 15,000 characters, but the content is clearly an announcement of the notice publication rather than the AGM report or presentation. Therefore, this fits the category of AGM Information (AGM-R) as it relates to materials shared during the AGM process, specifically the notice publication. The document is not a full Annual Report, nor a voting result declaration, nor a proxy solicitation. It is a formal communication about the AGM notice publication.
2024-09-09 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.